NIAID head says bird flu research restrictions should remain in place | WHO update on Ebola outbreak in Uganda | Is childhood pertussis vaccine less effective than we thought? | CDC watching as variant H3N2 as cases climb | Food-borne illnesses not diminishing, CDC finds | EPA and USDA announce first-ever microbial risk assessment guidance | NIST official testifies on threat detection science for national security | National Strategy for Biosurveillance | UN urges for global moratorium on research using deadly livestock virus | Maximizing MarForRes CBRN capability as a force asset | Sanofi Pasteur’s dengue vaccine demonstrates proof of efficacy | Achieving consistent multiple daily low-dose Bacillus anthracis spore inhalation exposures | CSIRO to supply antibodies in search for new, safe and affordable rotavirus vaccines | Comparison of gene-based smallpox vaccine with MVA in non-human primates | Stanford researchers produce first complete computer model of an organism

See what we’re reading this week at Global Biodefense on topics like the Ebola outbreak in Uganda, Biosurveillance strategy, smallpox vaccine studies, pertussis resurgence and more…

NIAID head says bird flu research restrictions should remain in place (NTI GSN)

WHO update on Ebola outbreak in Uganda (WHO)

Is childhood pertussis vaccine less effective than we thought? (Wired)

CDC watching as variant H3N2 as cases climb (CIDRAP)

Food-borne illnesses not diminishing, CDC finds (Washington Post)

EPA and USDA announce first-ever microbial risk assessment guidance (EPA)

NIST official testifies on threat detection science for national security (NIST)

National Strategy for Biosurveillance .pdf (WhiteHouse.gov)

UN urges for global moratorium on research using deadly livestock virus (UN)

Maximizing MarForRes CBRN capability as a force asset (USMC)

Sanofi Pasteur’s dengue vaccine demonstrates proof of efficacy .pdf (Sanofi)

Achieving consistent multiple daily low-dose Bacillus anthracis spore inhalation exposures (EPA HSR)